In the first study to systematically examine the public investments in mRNA vaccines, researchers have found that the U.S. government was substantially invested in mRNA vaccine technology before the COVID pandemic.
Published in the British Medical Journal on March 1, the study found that the government invested $31.9 billion in mRNA vaccines and technologies between 1985 and 2022, of which at least $337 million was invested pre-pandemic.
